{"id":"https://openalex.org/W2000590100","doi":"https://doi.org/10.1007/s11095-006-9111-5","title":"Transition Metal-Mediated Liposomal Encapsulation of Irinotecan (CPT-11) Stabilizes the Drug in the Therapeutically Active Lactone Conformation","display_name":"Transition Metal-Mediated Liposomal Encapsulation of Irinotecan (CPT-11) Stabilizes the Drug in the Therapeutically Active Lactone Conformation","alternate_titles":[],"publication_year":2006,"publication_date":"2006-10-25","ids":{"openalex":"https://openalex.org/W2000590100","doi":"https://doi.org/10.1007/s11095-006-9111-5","mag":"2000590100","pmid":"https://pubmed.ncbi.nlm.nih.gov/17063397"},"language":"en","primary_location":{"id":"doi:10.1007/s11095-006-9111-5","doi":"https://doi.org/10.1007/s11095-006-9111-5","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s11095-006-9111-5","pdf_url":null,"source":{"id":"https://openalex.org/S103865650","display_name":"Pharmaceutical Research","issn_l":"0724-8741","issn":["0724-8741","1573-904X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutical Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2000590100"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113658570","display_name":"Euan Ramsay","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1289530486","display_name":"BC Cancer Agency","ror":"https://ror.org/03sfybe47","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1289530486"]}],"countries":["CA"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Euan Ramsay","raw_affiliation_strings":["Department of Advanced Therapeutics, BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, Canada, V5Z 1L3. eramsay@bccrc.ca","Department of Advanced Therapeutics, BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, Canada, V5Z 1L3"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Advanced Therapeutics, BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, Canada, V5Z 1L3. eramsay@bccrc.ca","institution_ids":["https://openalex.org/I1289530486"]},{"raw_affiliation_string":"Department of Advanced Therapeutics, BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, Canada, V5Z 1L3","institution_ids":["https://openalex.org/I1289530486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037694325","display_name":"Jehan Alnajim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1289530486","display_name":"BC Cancer Agency","ror":"https://ror.org/03sfybe47","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1289530486"]}],"countries":["CA"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jehan Alnajim","raw_affiliation_strings":["Department of Advanced Therapeutics, BC Cancer Agency, Vancouver, Canada","Department of Advanced Therapeutics, BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, Canada, V5Z 1L3"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Advanced Therapeutics, BC Cancer Agency, Vancouver, Canada","institution_ids":["https://openalex.org/I1289530486"]},{"raw_affiliation_string":"Department of Advanced Therapeutics, BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, Canada, V5Z 1L3","institution_ids":["https://openalex.org/I1289530486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110037969","display_name":"Malathi Anantha","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1289530486","display_name":"BC Cancer Agency","ror":"https://ror.org/03sfybe47","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1289530486"]}],"countries":["CA"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Malathi Anantha","raw_affiliation_strings":["Department of Advanced Therapeutics, BC Cancer Agency, Vancouver, Canada","Department of Advanced Therapeutics, BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, Canada, V5Z 1L3"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Advanced Therapeutics, BC Cancer Agency, Vancouver, Canada","institution_ids":["https://openalex.org/I1289530486"]},{"raw_affiliation_string":"Department of Advanced Therapeutics, BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, Canada, V5Z 1L3","institution_ids":["https://openalex.org/I1289530486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016431479","display_name":"Amandeep Singh Taggar","orcid":"https://orcid.org/0000-0002-3562-5890","observed_orcids":["https://orcid.org/0000-0002-3562-5890"]},"institutions":[{"id":"https://openalex.org/I1289530486","display_name":"BC Cancer Agency","ror":"https://ror.org/03sfybe47","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1289530486"]},{"id":"https://openalex.org/I141945490","display_name":"University of British Columbia","ror":"https://ror.org/03rmrcq20","country_code":"CA","type":"education","lineage":["https://openalex.org/I141945490"]}],"countries":["CA"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Aman Taggar","raw_affiliation_strings":["Department of Advanced Therapeutics, BC Cancer Agency, Vancouver, Canada","Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada","Department of Advanced Therapeutics, BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, Canada, V5Z 1L3"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Advanced Therapeutics, BC Cancer Agency, Vancouver, Canada","institution_ids":["https://openalex.org/I1289530486"]},{"raw_affiliation_string":"Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada","institution_ids":["https://openalex.org/I141945490"]},{"raw_affiliation_string":"Department of Advanced Therapeutics, BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, Canada, V5Z 1L3","institution_ids":["https://openalex.org/I1289530486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044002928","display_name":"Anitha M. Thomas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1289530486","display_name":"BC Cancer Agency","ror":"https://ror.org/03sfybe47","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1289530486"]}],"countries":["CA"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Anitha Thomas","raw_affiliation_strings":["Department of Advanced Therapeutics, BC Cancer Agency, Vancouver, Canada","Department of Advanced Therapeutics, BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, Canada, V5Z 1L3"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Advanced Therapeutics, BC Cancer Agency, Vancouver, Canada","institution_ids":["https://openalex.org/I1289530486"]},{"raw_affiliation_string":"Department of Advanced Therapeutics, BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, Canada, V5Z 1L3","institution_ids":["https://openalex.org/I1289530486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015373993","display_name":"Katarina Edwards","orcid":"https://orcid.org/0000-0003-0674-2219","observed_orcids":["https://orcid.org/0000-0003-0674-2219"]},"institutions":[{"id":"https://openalex.org/I123387679","display_name":"Uppsala University","ror":"https://ror.org/048a87296","country_code":"SE","type":"education","lineage":["https://openalex.org/I123387679"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Katarina Edwards","raw_affiliation_strings":["Department of Physical Chemistry, Uppsala University, Uppsala, Sweden","Department of Physical Chemistry, Uppsala University, Box 539, S-751 23, Uppsala, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Physical Chemistry, Uppsala University, Uppsala, Sweden","institution_ids":["https://openalex.org/I123387679"]},{"raw_affiliation_string":"Department of Physical Chemistry, Uppsala University, Box 539, S-751 23, Uppsala, Sweden","institution_ids":["https://openalex.org/I123387679"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010810577","display_name":"G\u00f6ran Karlsson","orcid":"https://orcid.org/0000-0001-8197-754X","observed_orcids":["https://orcid.org/0000-0001-8197-754X"]},"institutions":[{"id":"https://openalex.org/I123387679","display_name":"Uppsala University","ror":"https://ror.org/048a87296","country_code":"SE","type":"education","lineage":["https://openalex.org/I123387679"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"G\u00f6ran Karlsson","raw_affiliation_strings":["Department of Physical Chemistry, Uppsala University, Uppsala, Sweden","Department of Physical Chemistry, Uppsala University, Box 539, S-751 23, Uppsala, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Physical Chemistry, Uppsala University, Uppsala, Sweden","institution_ids":["https://openalex.org/I123387679"]},{"raw_affiliation_string":"Department of Physical Chemistry, Uppsala University, Box 539, S-751 23, Uppsala, Sweden","institution_ids":["https://openalex.org/I123387679"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110102526","display_name":"Murray S. Webb","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1289530486","display_name":"BC Cancer Agency","ror":"https://ror.org/03sfybe47","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1289530486"]}],"countries":["CA"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Murray Webb","raw_affiliation_strings":["Department of Advanced Therapeutics, BC Cancer Agency, Vancouver, Canada","Department of Advanced Therapeutics, BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, Canada, V5Z 1L3"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Advanced Therapeutics, BC Cancer Agency, Vancouver, Canada","institution_ids":["https://openalex.org/I1289530486"]},{"raw_affiliation_string":"Department of Advanced Therapeutics, BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, Canada, V5Z 1L3","institution_ids":["https://openalex.org/I1289530486"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5070792731","display_name":"Marcel B. Bally","orcid":"https://orcid.org/0000-0002-1994-4787","observed_orcids":["https://orcid.org/0000-0002-1994-4787"]},"institutions":[{"id":"https://openalex.org/I1289530486","display_name":"BC Cancer Agency","ror":"https://ror.org/03sfybe47","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1289530486"]},{"id":"https://openalex.org/I141945490","display_name":"University of British Columbia","ror":"https://ror.org/03rmrcq20","country_code":"CA","type":"education","lineage":["https://openalex.org/I141945490"]}],"countries":["CA"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Marcel Bally","raw_affiliation_strings":["Department of Advanced Therapeutics, BC Cancer Agency, Vancouver, Canada","Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada","Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada","Department of Pathology and Laboratory Medicine, University of British Columbia, 2211 Wesbrook Mall, Vancouver, BC, Canada,  V6T 2B5"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Advanced Therapeutics, BC Cancer Agency, Vancouver, Canada","institution_ids":["https://openalex.org/I1289530486"]},{"raw_affiliation_string":"Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada","institution_ids":["https://openalex.org/I141945490"]},{"raw_affiliation_string":"Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada","institution_ids":["https://openalex.org/I141945490"]},{"raw_affiliation_string":"Department of Pathology and Laboratory Medicine, University of British Columbia, 2211 Wesbrook Mall, Vancouver, BC, Canada,  V6T 2B5","institution_ids":["https://openalex.org/I141945490"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5113658570"],"corresponding_institution_ids":["https://openalex.org/I1289530486"],"apc_list":{"value":4690,"currency":"USD","value_usd":4690},"apc_paid":null,"fwci":1.7388,"has_fulltext":false,"cited_by_count":55,"citation_normalized_percentile":{"value":0.80818441,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"23","issue":"12","first_page":"2799","last_page":"2808"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.002199999988079071,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/irinotecan","display_name":"irinotecan","score":1.0},{"id":"https://openalex.org/keywords/liposomal-drug-delivery","display_name":"liposomal drug delivery","score":0.75},{"id":"https://openalex.org/keywords/transition-metal-complexation","display_name":"transition metal complexation","score":0.8100000023841858},{"id":"https://openalex.org/keywords/copper","display_name":"copper","score":0.6570000052452087},{"id":"https://openalex.org/keywords/zinc","display_name":"zinc","score":0.949999988079071},{"id":"https://openalex.org/keywords/drug-stability","display_name":"drug stability","score":0.7070000171661377},{"id":"https://openalex.org/keywords/transmembrane-ph-gradient","display_name":"transmembrane pH gradient","score":0.8740000128746033},{"id":"https://openalex.org/keywords/internal-ph","display_name":"internal pH","score":0.675000011920929},{"id":"https://openalex.org/keywords/nigericin","display_name":"nigericin","score":0.8690000176429749},{"id":"https://openalex.org/keywords/anticancer-drug-encapsulation","display_name":"anticancer drug encapsulation","score":0.6209999918937683}],"concepts":[{"id":"https://openalex.org/C185154212","wikidata":"https://www.wikidata.org/wiki/Q410454","display_name":"Liposome","level":2,"score":0.9085085391998291},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.8530770540237427},{"id":"https://openalex.org/C2780259306","wikidata":"https://www.wikidata.org/wiki/Q412197","display_name":"Irinotecan","level":4,"score":0.8210092782974243},{"id":"https://openalex.org/C2780508388","wikidata":"https://www.wikidata.org/wiki/Q1750127","display_name":"SN-38","level":5,"score":0.5090858340263367},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.5086701512336731},{"id":"https://openalex.org/C2778918659","wikidata":"https://www.wikidata.org/wiki/Q186915","display_name":"Phospholipid","level":3,"score":0.4831477999687195},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4525541365146637},{"id":"https://openalex.org/C2776612806","wikidata":"https://www.wikidata.org/wiki/Q59078","display_name":"Lactone","level":2,"score":0.4477623701095581},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.44345471262931824},{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.4424680471420288},{"id":"https://openalex.org/C41625074","wikidata":"https://www.wikidata.org/wiki/Q176088","display_name":"Membrane","level":2,"score":0.40996965765953064},{"id":"https://openalex.org/C12554922","wikidata":"https://www.wikidata.org/wiki/Q7100","display_name":"Biophysics","level":1,"score":0.38865429162979126},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.37703296542167664},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.2488192915916443},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.20188051462173462},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.16924867033958435},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.0},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077146","descriptor_name":"Irinotecan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D002264","descriptor_name":"Carboxylic Acids","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D002851","descriptor_name":"Chromatography, High Pressure Liquid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002855","descriptor_name":"Chromatography, Thin Layer","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003300","descriptor_name":"Copper","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D004337","descriptor_name":"Drug Carriers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004339","descriptor_name":"Drug Compounding","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006863","descriptor_name":"Hydrogen-Ion Concentration","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007783","descriptor_name":"Lactones","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008081","descriptor_name":"Liposomes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020285","descriptor_name":"Cryoelectron Microscopy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D028561","descriptor_name":"Transition Elements","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1007/s11095-006-9111-5","doi":"https://doi.org/10.1007/s11095-006-9111-5","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s11095-006-9111-5","pdf_url":null,"source":{"id":"https://openalex.org/S103865650","display_name":"Pharmaceutical Research","issn_l":"0724-8741","issn":["0724-8741","1573-904X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutical Research","raw_type":"journal-article"},{"id":"pmid:17063397","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17063397","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutical research","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.504800021648407}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320334506","display_name":"Canadian Institutes of Health Research","ror":"https://ror.org/01gavpb45"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":37,"referenced_works":["https://openalex.org/W165178680","https://openalex.org/W1502025781","https://openalex.org/W1549846058","https://openalex.org/W1969972386","https://openalex.org/W1971373442","https://openalex.org/W1972018837","https://openalex.org/W1975616471","https://openalex.org/W1977279056","https://openalex.org/W2006088165","https://openalex.org/W2006337478","https://openalex.org/W2023407704","https://openalex.org/W2023626223","https://openalex.org/W2029823852","https://openalex.org/W2036944284","https://openalex.org/W2039467756","https://openalex.org/W2045230140","https://openalex.org/W2049043423","https://openalex.org/W2049398377","https://openalex.org/W2051041111","https://openalex.org/W2055265722","https://openalex.org/W2073683299","https://openalex.org/W2086179083","https://openalex.org/W2097272023","https://openalex.org/W2100402476","https://openalex.org/W2103408956","https://openalex.org/W2120694339","https://openalex.org/W2126662679","https://openalex.org/W2142197209","https://openalex.org/W2157332329","https://openalex.org/W2159921901","https://openalex.org/W2163409320","https://openalex.org/W2163938074","https://openalex.org/W2314927739","https://openalex.org/W2332668852","https://openalex.org/W2411500091","https://openalex.org/W2490519100","https://openalex.org/W2595776066"],"related_works":["https://openalex.org/W1570480111","https://openalex.org/W1971373442","https://openalex.org/W1991790115","https://openalex.org/W1974822561","https://openalex.org/W2039049126","https://openalex.org/W3135432136","https://openalex.org/W2342671709","https://openalex.org/W2389369879","https://openalex.org/W7162320426"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2000590100","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
